rs61734958

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_022089.4(ATP13A2):​c.2093T>C​(p.Val698Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000823 in 1,613,402 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V698V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0045 ( 4 hom., cov: 33)
Exomes 𝑓: 0.00043 ( 2 hom. )

Consequence

ATP13A2
NM_022089.4 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0470

Publications

3 publications found
Variant links:
Genes affected
ATP13A2 (HGNC:30213): (ATPase cation transporting 13A2) This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2008]
ATP13A2 Gene-Disease associations (from GenCC):
  • Kufor-Rakeb syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, ClinGen, Labcorp Genetics (formerly Invitae), Illumina
  • autosomal recessive spastic paraplegia type 78
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • parkinsonism due to ATP13A2 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035814047).
BP6
Variant 1-16992042-A-G is Benign according to our data. Variant chr1-16992042-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 533810.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00455 (693/152368) while in subpopulation AFR AF = 0.0161 (670/41592). AF 95% confidence interval is 0.0151. There are 4 homozygotes in GnomAd4. There are 316 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022089.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP13A2
NM_022089.4
MANE Select
c.2093T>Cp.Val698Ala
missense
Exon 19 of 29NP_071372.1Q9NQ11-1
ATP13A2
NM_001141973.3
c.2078T>Cp.Val693Ala
missense
Exon 19 of 29NP_001135445.1Q9NQ11-3
ATP13A2
NM_001141974.3
c.2078T>Cp.Val693Ala
missense
Exon 19 of 27NP_001135446.1Q9NQ11-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP13A2
ENST00000326735.13
TSL:1 MANE Select
c.2093T>Cp.Val698Ala
missense
Exon 19 of 29ENSP00000327214.8Q9NQ11-1
ATP13A2
ENST00000452699.5
TSL:1
c.2078T>Cp.Val693Ala
missense
Exon 19 of 29ENSP00000413307.1Q9NQ11-3
ATP13A2
ENST00000341676.9
TSL:1
c.2078T>Cp.Val693Ala
missense
Exon 19 of 27ENSP00000341115.5Q9NQ11-2

Frequencies

GnomAD3 genomes
AF:
0.00452
AC:
688
AN:
152250
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0160
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000981
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00126
AC:
315
AN:
250532
AF XY:
0.000900
show subpopulations
Gnomad AFR exome
AF:
0.0175
Gnomad AMR exome
AF:
0.000752
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.000491
GnomAD4 exome
AF:
0.000435
AC:
635
AN:
1461034
Hom.:
2
Cov.:
31
AF XY:
0.000389
AC XY:
283
AN XY:
726724
show subpopulations
African (AFR)
AF:
0.0156
AC:
522
AN:
33474
American (AMR)
AF:
0.000783
AC:
35
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86248
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52946
Middle Eastern (MID)
AF:
0.000695
AC:
4
AN:
5756
European-Non Finnish (NFE)
AF:
0.0000126
AC:
14
AN:
1111714
Other (OTH)
AF:
0.000961
AC:
58
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
43
86
128
171
214
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00455
AC:
693
AN:
152368
Hom.:
4
Cov.:
33
AF XY:
0.00424
AC XY:
316
AN XY:
74514
show subpopulations
African (AFR)
AF:
0.0161
AC:
670
AN:
41592
American (AMR)
AF:
0.000980
AC:
15
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68022
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
36
72
109
145
181
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00118
Hom.:
0
Bravo
AF:
0.00499
ESP6500AA
AF:
0.0197
AC:
87
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00166
AC:
201
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Inborn genetic diseases (1)
-
-
1
Kufor-Rakeb syndrome (1)
-
-
1
Kufor-Rakeb syndrome;C5567893:Autosomal recessive spastic paraplegia type 78 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
4.5
DANN
Benign
0.37
DEOGEN2
Benign
0.27
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.011
N
LIST_S2
Benign
0.51
T
MetaRNN
Benign
0.0036
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.29
N
PhyloP100
0.047
PrimateAI
Benign
0.40
T
PROVEAN
Benign
0.31
N
REVEL
Benign
0.026
Sift
Benign
0.76
T
Sift4G
Benign
0.76
T
Polyphen
0.0
B
Vest4
0.031
MVP
0.28
MPC
0.39
ClinPred
0.00079
T
GERP RS
-0.22
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.020
gMVP
0.31
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61734958; hg19: chr1-17318537; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.